Cue Biopharma Inc (CUE)
NASDAQ:CUE
US Market
Holding CUE?
Track your performance easily

Cue Biopharma (CUE) Financial Statements

580 Followers

Cue Biopharma Financial Overview

Cue Biopharma's market cap is currently ―. The company's EPS TTM is $-0.974; its P/E ratio is -1.69; Cue Biopharma is scheduled to report earnings on November 12, 2024, and the estimated EPS forecast is $-0.18. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 2.66M$ 1.72M$ 2.10M$ 1.38M$ 187.00K
Gross Profit$ 2.66M$ 1.72M$ 2.10M$ 1.38M$ 187.00K
EBIT$ -9.96M$ -12.11M$ -10.72M$ -12.95M$ -12.74M
EBITDA$ -9.85M$ -12.00M$ -9.86M$ -12.88M$ -12.70M
Net Income Common Stockholders$ -10.17M$ -12.35M$ -11.01M$ -13.19M$ -13.11M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 30.03M$ 41.03M$ 54.69M$ 57.89M$ 66.20M
Total Assets$ 42.33M$ 53.95M$ 68.89M$ 73.16M$ 81.68M
Total Debt$ 11.26M$ 13.00M$ 16.38M$ 18.04M$ 18.70M
Net Debt$ -18.77M$ -28.03M$ -38.31M$ -39.84M$ -47.49M
Total Liabilities$ 20.71M$ 23.91M$ 26.22M$ 27.16M$ 26.66M
Stockholders Equity$ 21.62M$ 30.04M$ 42.67M$ 46.00M$ 55.02M
Cash Flow-
Free Cash Flow$ -10.00M$ -9.84M$ -7.80M$ -10.37M$ -10.83M
Operating Cash Flow$ -9.99M$ -9.78M$ -7.80M$ -10.37M$ -10.83M
Investing Cash Flow$ -10.00K$ -55.00K$ 5.00M$ 5.00M$ 15.00M
Financing Cash Flow$ -1.00M$ 2.35M$ 4.59M$ 2.10M$ 388.00K
Currency in USD

Cue Biopharma Earnings and Revenue History

Cue Biopharma Debt to Assets

Cue Biopharma Cash Flow

Cue Biopharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis